In this issue:
Thrombosis with ChAdOx1-S SARS-CoV-2 vaccine
Intermediate- vs. standard prophylactic anticoagulation in ICU-admitted COVID-19
Eprenetapopt and azacitidine in TP53-mutated MDS
Oral azacitidine for lower-risk MDS
Fiix-NR monitoring during warfarin management
Discontinuing eculizumab in atypical haemolytic-uraemic syndrome
Prophylactic high-dose methotrexate in high-risk DLBCL
Hydroxycarbamide + low-dose thalidomide in transfusion-dependent β-thalassaemia
Plerixafor + TBI-based myeloablative conditioning for allogeneic SCT
Salvage ruxolitinib + doxorubicin/etoposide/methylprednisolone in haemophagocytic lymphohistiocytosis
Please login below to download this issue (PDF)